FEIBA VH IMMUNO ANTI INHIBITOR
FEIBA VH IMMUNO ANTI INHIBITOR
Discontinued
DIN Number
00609137
Drug Class
Human
Market Date
Dec 31, 1986
Company
HC
osterreichisches institut fur haemoderivate ges m.b.h.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00609137
AIG Number0516347001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (5)
ANTIHEMOPHILIC FACTOR (HUMAN)Active
Strength: 4 UNIT / ML
Monograph: ANTIHEMOPHILIC FACTOR (HUMAN)
COAGULATION FACTOR II (HUMAN)Active
Strength: null NIL / ML
Monograph: COAGULATION FACTOR II (HUMAN)
COAGULATION FACTOR VII (HUMAN)Active
Strength: null NIL / ML
Monograph: COAGULATION FACTOR VII (HUMAN)
COAGULATION FACTOR X (HUMAN)Active
Strength: null NIL / ML
Monograph: COAGULATION FACTOR X (HUMAN)
FACTOR IX COMPLEX HUMANActive
Strength: null NIL / ML
Monograph: FACTOR IX COMPLEX HUMAN